Dec 14 – Theraclion delivers its 2023 objectives
Oct 24 – First patients treated in the FDA pivotal study
April 17 – FDA approval for SONOVEIN pivotal study
Discover a SONOVEIN treatment
CoP E-meeting on HIFU led by Dr. Mark Whiteley (UK)
FUS 2022 presentation by Dr. Steve Elias
Theraclion's mission is to develop non-invasive, intelligent, robotic platforms that reduce healthcare system and human costs and unleash treatment opportunities.
SONOVEIN® is the only robotic and 100% non-invasive echotherapy system treating varicose veins in a non-surgical environment. It doesn‘t need any additional accessories and leaves no scars. Our newest version, SONOVEIN® HD, includes leading-edge imaging capabilities from SuperSonic Imagine.
ECHOPULSE® is a completely non-invasive robot for echotherapy treatment of thyroid nodules and breast fibroadenoma. It can be operated by a single person in a standard physicians’ office. It leaves no scars and maintains the thyroid function and the integrity of the breast tissue.
Echotherapy works like a magnifying glass, concentrating light waves to a focal point, but instead using therapeutic ultrasound, or High-Intensity Focused Ultrasound (HIFU). Echotherapy's main advantage for the patient is that it is non-invasive. This implies that it does not require a sterile environment (like an operation theater) or incisions, it does not leave scars and allows the patient an immediate return to their daily activities.PATIENT WEBSITE